Inflammatory Skin Disease
Clinical research in atopic dermatitis focuses on immune-mediated skin inflammation and persistent pruritus, with attention to disease control in moderate to severe cases.
- Atopic dermatitis
- Immune dysregulation
- Chronic pruritic dermatitis
The sponsor’s portfolio places substantial emphasis on dermatologic inflammation and conditions driven by aberrant immune signaling.
Gastrointestinal Immune Disorders
Research activity extends to ulcerative colitis, celiac disease, and eosinophilic esophagitis, reflecting a focus on inflammatory and immune-based disorders of the digestive tract.
- Ulcerative colitis
- Celiac disease
- Eosinophilic esophagitis
These programs address mucosal inflammation, food-related immune activation, and eosinophil-associated disease in the gastrointestinal tract.
Rheumatologic Inflammation
Clinical studies in moderate to severe rheumatoid arthritis center on joint inflammation, systemic immune activation, and the burden of chronic autoimmune disease.
- Rheumatoid arthritis
- Autoimmune joint disease
- Systemic inflammation
This area reflects interest in therapies aimed at controlling inflammatory pathways involved in synovial disease and progressive joint damage.
Targeted Immunology Programs
The sponsor also funds research into investigational immunology programs, including work associated with ANB032, rosnilimab, and ANB033, indicating a broader interest in pathway-directed immune modulation.
- Immune pathway modulation
- Inflammatory disease biology
- Translational immunology
These studies connect dermatology, gastroenterology, and rheumatology through shared mechanisms of immune-mediated inflammation.
